has reported Standalone financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 10.1583 crores during the period ended March 31, 2022 as compared to Rs. 4.8869 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. -0.7160 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 0.9534 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. -0.12 for the period ended March 31, 2022 as compared to Rs. 0.15 for the period ended December 31, 2021.
Total Income | ₹ 10.1583 crs | ₹4.8869 crs | 107.87% |
Net Profit | ₹-0.7160 crs | ₹0.9534 crs | -175.10% |
EPS | ₹-0.12 | ₹0.15 | -180.00% |
Financial Results (Q4 FY2022) - YoY Comparison The company has reported total income of Rs. 10.1583 crores during the period ended March 31, 2022 as compared to Rs.9.9169 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.-0.7160 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.-0.9870 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.-0.12 for the period ended March 31, 2022 as compared to Rs.-1.60 for the period ended March 31, 2021.
Total Income | ₹ 10.1583 crs | ₹9.9169 crs | 2.43% |
Net Profit | ₹-0.7160 crs | ₹-0.9870 crs | 27.46% |
EPS | ₹-0.12 | ₹-1.60 | 92.50% |
Financial Results (Year Ended FY2022) - YoY Comparison The company has reported total income of Rs.28.7386 crores during the Financial Year ended March 31, 2022 as compared to Rs.50.0157 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.2.2241 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.0.0882 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.0.36 for the Financial Year ended March 31, 2022 as compared to Rs.0.14 for the Financial Year ended March 31, 2021.
Total Income | ₹28.7386 crs | ₹50.0157 crs | -42.54% |
Net Profit | ₹2.2241 crs | ₹0.0882 crs | 2,421.66% |
EPS | ₹0.36 | ₹0.14 | 157.14% |
Source : Equity Bulls
Keywords
EarumPharmaceuticals
Q4FY22
FY2022
ResultUpdate